Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
In response to growing demand for clinical supply of active pharmaceutical ingredients, Cambrex will add kilogram- and pilot-scale manufacturing capacity at its High Point, N.C., facility. Cambrex will acquire a 3,250-m2 facility it currently leases as well as an adjacent 4,200-m2 building. Cambrex got the High Point facility in 2016 with the $25 million acquisition of PharmaCore. Since last year it has added a 1,000-m2 analytical laboratory at the site and completed a clinical-scale manufacturing suite.
This article has been sent to the following recipient: